Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Post COVID-19 condition of the Omicron variant of SARS-CoV-2

View ORCID ProfileShinichiro Morioka, View ORCID ProfileShinya Tsuzuki, View ORCID ProfileMichiyo Suzuki, View ORCID ProfileMari Terada, Masako Akashi, Yasuyo Osanai, Chika Kuge, Mio Sanada, Keiko Tanaka, Taketomo Maruki, View ORCID ProfileKozue Takahashi, View ORCID ProfileSho Saito, View ORCID ProfileKayoko Hayakawa, Katsuji Teruya, View ORCID ProfileMasayuki Hojo, View ORCID ProfileNorio Ohmagari
doi: https://doi.org/10.1101/2022.05.12.22274990
Shinichiro Morioka
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
2Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan
3AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shinichiro Morioka
  • For correspondence: shmorioka@hosp.ncgm.go.jp
Shinya Tsuzuki
3AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
4Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shinya Tsuzuki
Michiyo Suzuki
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michiyo Suzuki
Mari Terada
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
5Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mari Terada
Masako Akashi
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuyo Osanai
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chika Kuge
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mio Sanada
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiko Tanaka
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taketomo Maruki
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kozue Takahashi
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kozue Takahashi
Sho Saito
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sho Saito
Kayoko Hayakawa
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
3AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kayoko Hayakawa
Katsuji Teruya
6AIDS Clinical Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Hojo
7Division of Respiratory Medicine, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masayuki Hojo
Norio Ohmagari
1Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
3AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Norio Ohmagari
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background No epidemiological data on post coronavirus disease (COVID-19) condition due to Omicron variant has been reported yet.

Methods This was as a single-center, cross-sectional study, that interviewed via telephone the patients who recovered from Omicron COVID-19 infection (Omicron group), and surveyed via self-reporting questionnaire those patients infected with other strains (control group). Data on patients’ characteristics, information regarding the acute-phase COVID-19, as well as presence and duration of COVID-19-related symptoms were obtained. Post COVID-19 condition in this study was defined as a symptom that lasted at least 2 months within 3 months since the onset of COVID-19. We investigated and compared the prevalence of post COVID-19 condition in both groups after performing propensity score matching.

Results We conducted interviews for 53 out of 128 patients with Omicron, and obtained 502 responses in the control group. After matching, 18 patients each in Omicron and control group had improved covariate balance of the older adult, female sex, obese patients, and vaccination status. There were no significant differences in the prevalence of each post-acute COVID-19 symptoms between the two groups. The numbers of patients with at least one post-acute COVID-19 symptom in the Omicron and the control group were 1 (5.6%) and 10 (55.6%) (p=0.003), respectively.

Conclusion The prevalence of post Omicron COVID-19 conditions was less than that of the other strains. Further research with more participants is needed to investigate the precise epidemiology of post COVID-19 condition of Omicron, and its impact on health-related quality of life and social productivity.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Health, Labor and Welfare Policy Research Grants, Research on Emerging and Reemerging Infectious Diseases and Immunization (grant number 20HA1006).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was reviewed and approved by the ethics committee of the Center Hospital of the National Center for Global Health and Medicine (NCGM) (NCGM-G-004406-00, NCGM-G-004439-00).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Post COVID-19 condition of the Omicron variant of SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Post COVID-19 condition of the Omicron variant of SARS-CoV-2
Shinichiro Morioka, Shinya Tsuzuki, Michiyo Suzuki, Mari Terada, Masako Akashi, Yasuyo Osanai, Chika Kuge, Mio Sanada, Keiko Tanaka, Taketomo Maruki, Kozue Takahashi, Sho Saito, Kayoko Hayakawa, Katsuji Teruya, Masayuki Hojo, Norio Ohmagari
medRxiv 2022.05.12.22274990; doi: https://doi.org/10.1101/2022.05.12.22274990
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Post COVID-19 condition of the Omicron variant of SARS-CoV-2
Shinichiro Morioka, Shinya Tsuzuki, Michiyo Suzuki, Mari Terada, Masako Akashi, Yasuyo Osanai, Chika Kuge, Mio Sanada, Keiko Tanaka, Taketomo Maruki, Kozue Takahashi, Sho Saito, Kayoko Hayakawa, Katsuji Teruya, Masayuki Hojo, Norio Ohmagari
medRxiv 2022.05.12.22274990; doi: https://doi.org/10.1101/2022.05.12.22274990

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)